Who is EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals, Inc., is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.

What's new at EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Maintenance Treatment of Wet AMD 8-1-22 EyePoint Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022 7-27-22

Is EyePoint Pharmaceuticals under investigation?

New York, New York-- (Newsfile Corp. - January 4, 2023) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against EyePoint Pharmaceuticals (“Eyepoint” or the “Company”) (NASDAQ: EYPT).